Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 69434-013

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69434-013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhejiang Yongtai Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Esomeprazolemagnesiumdelayed Releasecapsules 01)

FDA Label Image

Figure 2 : Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazolemagnesiumdelayed Releasecapsules 02)

FDA Label Image

Figure 3 Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazolemagnesiumdelayed Releasecapsules 03)

This text is not readable.*

FDA Label Image

Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazolemagnesiumdelayed Releasecapsules 04)

FDA Label Image

Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazolemagnesiumdelayed Releasecapsules 05)

This text refers to the percent of patients who were symptom-free after taking Esomeprazole Magnesium Delayed-Release Capsules at different dosages, including 40 mg and 20 mg, compared to those who took a placebo. The data presented is useful in evaluating the effectiveness of the medication in providing relief from symptoms.*

FDA Label Image

20mg 30ct Bottle (Esomeprazolemagnesiumdelayed Releasecapsules 20mg 30s 06)

FDA Label Image

40mg 30ct Bottle (Esomeprazolemagnesiumdelayed Releasecapsules 40mg 30s 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.